90 related articles for article (PubMed ID: 27573867)
1. Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy.
Kim JS; Kang SJ; Jeong HY; Kim MW; Park SI; Lee YK; Kim HS; Kim KS; Park YS
Int J Oncol; 2016 Sep; 49(3):1130-8. PubMed ID: 27573867
[TBL] [Abstract][Full Text] [Related]
2. Sendai viroplexes for epidermal growth factor receptor-directed delivery of interleukin-12 and salmosin genes to cancer cells.
Kim JS; Kim MW; Jeong HY; Kang SJ; Park SI; Lee YK; Kim HS; Kim KS; Park YS
J Gene Med; 2016 Jul; 18(7):112-23. PubMed ID: 27191929
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles.
Kim JS; Kim MW; Kang SJ; Jeong HY; Park SI; Lee YK; Kim HS; Kim KS; Park YS
Int J Nanomedicine; 2018; 13():4817-4830. PubMed ID: 30214190
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors.
Kim SI; Kim KS; Kim HS; Kim DS; Jang Y; Chung KH; Park YS
Cancer Res; 2003 Oct; 63(19):6458-62. PubMed ID: 14559837
[TBL] [Abstract][Full Text] [Related]
5. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.
Xu L; Tang WH; Huang CC; Alexander W; Xiang LM; Pirollo KF; Rait A; Chang EH
Mol Med; 2001 Oct; 7(10):723-34. PubMed ID: 11713371
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW
Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174
[TBL] [Abstract][Full Text] [Related]
7. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis by salmosin expressed in vitro.
Kim SI; Kim KS; Kim HS; Choi MM; Kim DS; Chung KH; Park YS
Oncol Res; 2004; 14(4-5):227-33. PubMed ID: 14977354
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs.
Lee YK; Lee TS; Song IH; Jeong HY; Kang SJ; Kim MW; Ryu SH; Jung IH; Kim JS; Park YS
Cancer Gene Ther; 2015 Jul; 22(7):335-43. PubMed ID: 25857361
[TBL] [Abstract][Full Text] [Related]
10. Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody.
Lee CH; Hsiao M; Tseng YL; Chang FH
J Biomed Sci; 2003; 10(3):337-44. PubMed ID: 12711861
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis.
Rodrigo-Garzón M; Berraondo P; Ochoa L; Zulueta JJ; González-Aseguinolaza G
Cancer Gene Ther; 2010 Jan; 17(1):20-7. PubMed ID: 19575045
[TBL] [Abstract][Full Text] [Related]
13. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.
Kang IC; Kim DS; Jang Y; Chung KH
Biochem Biophys Res Commun; 2000 Aug; 275(1):169-73. PubMed ID: 10944460
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection.
Petrilli R; Eloy JO; Saggioro FP; Chesca DL; de Souza MC; Dias MVS; daSilva LLP; Lee RJ; Lopez RFV
J Control Release; 2018 Aug; 283():151-162. PubMed ID: 29864476
[TBL] [Abstract][Full Text] [Related]
15. Complex formation with plasmid DNA increases the cytotoxicity of cationic liposomes.
Nguyen LT; Atobe K; Barichello JM; Ishida T; Kiwada H
Biol Pharm Bull; 2007 Apr; 30(4):751-7. PubMed ID: 17409515
[TBL] [Abstract][Full Text] [Related]
16. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
[TBL] [Abstract][Full Text] [Related]
18. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.
Asselin-Paturel C; Lassau N; Guinebretière JM; Zhang J; Gay F; Bex F; Hallez S; Leclere J; Peronneau P; Mami-Chouaib F; Chouaib S
Gene Ther; 1999 Apr; 6(4):606-15. PubMed ID: 10476220
[TBL] [Abstract][Full Text] [Related]
19. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
[TBL] [Abstract][Full Text] [Related]
20. Prenyl Ammonium Salts--New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
Grecka E; Statkiewicz M; Gorska A; Biernacka M; Grygorowicz MA; Masnyk M; Chmielewski M; Gawarecka K; Chojnacki T; Swiezewska E; Malecki M
PLoS One; 2016; 11(4):e0153633. PubMed ID: 27088717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
